IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lyra Therapeutics Inc (LYRA)

CUSIP: 55234L105 | NASDAQ | Healthcare · Biotechnology | Micro Cap | 179 institutional holders

Quarters

Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2025

IFP Advisors, Inc300
0.0% of portfolio›$26
StyleTurnoverLocationFiled
IFP Advisors, Inc
300$260.0%GrowthLowTampa, FL2025-07-24